Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Immunotherapy for metastatic melanoma.

Zito CR, Kluger HM.

J Cell Biochem. 2012 Mar;113(3):725-34. doi: 10.1002/jcb.23402. Review.

PMID:
22006439
[PubMed - indexed for MEDLINE]
2.

Immunotherapy as an adjuvant therapy in the management of advanced, surgically resected, melanoma.

Kalani AD, Jack A, Montenegro G, Degliuomini J, Wallack MK.

G Ital Dermatol Venereol. 2008 Feb;143(1):59-70. Review.

PMID:
18833052
[PubMed - indexed for MEDLINE]
3.

Cytokine-based therapy and biochemotherapy for advanced melanoma.

Atkins MB.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2353s-2358s. Review.

PMID:
16609058
[PubMed - indexed for MEDLINE]
Free Article
4.

Immunotherapy for the management of advanced melanoma: the next steps.

Zikich D, Schachter J, Besser MJ.

Am J Clin Dermatol. 2013 Aug;14(4):261-72. doi: 10.1007/s40257-013-0013-0. Review.

PMID:
23516145
[PubMed - indexed for MEDLINE]
5.

Update on immunotherapy for melanoma.

Ribas A.

J Natl Compr Canc Netw. 2006 Aug;4(7):687-94. Review.

PMID:
16884670
[PubMed - indexed for MEDLINE]
6.

Immunotherapy of melanoma.

Rietschel P, Chapman PB.

Hematol Oncol Clin North Am. 2006 Jun;20(3):751-66. Review.

PMID:
16762733
[PubMed - indexed for MEDLINE]
7.

Immunotherapy and experimental approaches for metastatic melanoma.

Atkins MB.

Hematol Oncol Clin North Am. 1998 Aug;12(4):877-902, viii. Review.

PMID:
9759585
[PubMed - indexed for MEDLINE]
8.

Melanoma and immunotherapy.

Eggermont AM, Schadendorf D.

Hematol Oncol Clin North Am. 2009 Jun;23(3):547-64, ix-x. doi: 10.1016/j.hoc.2009.03.009. Review.

PMID:
19464602
[PubMed - indexed for MEDLINE]
9.

Strategies to enhance the therapeutic activity of cancer vaccines: using melanoma as a model.

Berinstein NL.

Ann N Y Acad Sci. 2009 Sep;1174:107-17. doi: 10.1111/j.1749-6632.2009.04935.x.

PMID:
19769743
[PubMed - indexed for MEDLINE]
10.

Immunotherapy of distant metastatic disease.

Schadendorf D, Algarra SM, Bastholt L, Cinat G, Dreno B, Eggermont AM, Espinosa E, Guo J, Hauschild A, Petrella T, Schachter J, Hersey P.

Ann Oncol. 2009 Aug;20 Suppl 6:vi41-50. doi: 10.1093/annonc/mdp253. Review.

PMID:
19617297
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Ipilimumab and cancer immunotherapy: a new hope for advanced stage melanoma.

Mansh M.

Yale J Biol Med. 2011 Dec;84(4):381-9. Review.

PMID:
22180676
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

[Anti-CTLA-4 monoclonal antibody: a major step in the treatment of metastatic melanoma].

Robert C, Mateus C.

Med Sci (Paris). 2011 Oct;27(10):850-8. doi: 10.1051/medsci/20112710013. Epub 2011 Oct 21. Review. French.

PMID:
22027422
[PubMed - indexed for MEDLINE]
Free Article
13.

Ipilimumab targeting CD28-CTLA-4 axis: new hope in the treatment of melanoma.

Lens M, Testori A, Ferucci PF.

Curr Top Med Chem. 2012;12(1):61-6. Review.

PMID:
22196270
[PubMed - indexed for MEDLINE]
14.

Melanoma immunotherapy: historical precedents, recent successes and future prospects.

Raaijmakers MI, Rozati S, Goldinger SM, Widmer DS, Dummer R, Levesque MP.

Immunotherapy. 2013 Feb;5(2):169-82. doi: 10.2217/imt.12.162. Review.

PMID:
23413908
[PubMed - indexed for MEDLINE]
15.

Immunotherapy for melanoma: current status and perspectives.

Alexandrescu DT, Ichim TE, Riordan NH, Marincola FM, Di Nardo A, Kabigting FD, Dasanu CA.

J Immunother. 2010 Jul-Aug;33(6):570-90. doi: 10.1097/CJI.0b013e3181e032e8. Review.

PMID:
20551839
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit.

Yuan J, Gnjatic S, Li H, Powel S, Gallardo HF, Ritter E, Ku GY, Jungbluth AA, Segal NH, Rasalan TS, Manukian G, Xu Y, Roman RA, Terzulli SL, Heywood M, Pogoriler E, Ritter G, Old LJ, Allison JP, Wolchok JD.

Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20410-5. doi: 10.1073/pnas.0810114105. Epub 2008 Dec 12.

PMID:
19074257
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Immunotherapy for melanoma.

Kim CJ, Dessureault S, Gabrilovich D, Reintgen DS, Slingluff CL Jr.

Cancer Control. 2002 Jan-Feb;9(1):22-30. Review.

PMID:
11907463
[PubMed - indexed for MEDLINE]
Free Article
18.

The systemic treatment of advanced cutaneous melanoma.

Logan TF.

Facial Plast Surg Clin North Am. 2003 Feb;11(1):75-85. Review. No abstract available.

PMID:
15062290
[PubMed - indexed for MEDLINE]
19.

Review: anti-CTLA-4 antibody ipilimumab: case studies of clinical response and immune-related adverse events.

Weber J.

Oncologist. 2007 Jul;12(7):864-72. Review.

PMID:
17673617
[PubMed - indexed for MEDLINE]
Free Article
20.

Restoration of tumor equilibrium after immunotherapy for advanced melanoma: three illustrative cases.

Wilgenhof S, Pierret L, Corthals J, Van Nuffel AM, Heirman C, Roelandt T, De Coninck A, Verfaillie G, Vandenbroucke F, Van Riet I, Bonehill A, Thielemans K, Neyns B.

Melanoma Res. 2011 Apr;21(2):152-9. doi: 10.1097/CMR.0b013e328343ece0.

PMID:
21317818
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk